I see our product pretty simply as a radiotherapy in liquid form. .
Most radiotherapy isn’t curative. But it’s a useful adjuvant to a treatment regime. .
Pancreatic cancer needs as many options as it can find. Most treatments for pancreatic cancer doesn’t make the huge difference you like but they’re still used. Clinicians often feel powerless with it and tend to back off but the more options the more they might take it on
- Forums
- ASX - By Stock
- Ann: Consolidation/Split - OSL
OSL
oncosil medical ltd
Add to My Watchlist
6.84%
!
$1.02

I see our product pretty simply as a radiotherapy in liquid...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.065(6.84%) |
Mkt cap ! $14.43M |
Open | High | Low | Value | Volume |
$1.00 | $1.03 | 96.0¢ | $23.22K | 23.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 1042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 0.950 |
2 | 1349 | 0.940 |
1 | 627 | 0.920 |
1 | 23 | 0.910 |
1 | 20000 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 1042 | 1 |
1.030 | 27 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.080 | 48 | 1 |
Last trade - 14.07pm 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online